Evidence map›Paper›PMID 42706170›Full record

ArticleZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2026

[Inter-laboratory comparison of international standardized BCR::ABL1 (P210) mRNA of chronic myeloid leukemia patients by digital PCR].

Y Z Qin, D X Ma, Y Yao, Y M Zhu, Y L Zhang, H Liu, Y J Tang, S X Geng, C Qiao, C L Wang and 6 more

Abstract readComparative StudyMulticenter StudyEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Y Z QinPeking University People's Hospital, Peking University Institute of Hematology, Beijing 100044, China.
D X MaDepartment of Hematology, Qilu Hospital of Shandong University, Jinan 250012, China.
Y YaoState Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Y M ZhuShanghai Institute of Hematology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
Y L ZhangThe Center for Clinical Molecular Medical Detection, Laboratory Medicine Center, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
H LiuDepartment of Hematology, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi 830001, China.
Y J TangMedical Center of Hematology, the Second Affiliated Hospital of Army Medical University, Chongqing 400037, China.
S X GengDepartment of Hematology, Guangdong Provincial People's Hospital, Southern Medical University, Guangzhou 510080, China.
C QiaoDepartment of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing 210029, China.
C L WangPeking University People's Hospital Qingdao Hospital, Qingdao 266100, China.
M L ZhangDepartment of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
J H ZhangHematology Laboratory, Shengjing Hospital of China Medical University, Shenyang 110022, China.
L YaoHematology Research Laboratory, the First Affiliated Hospital of Soochow University, Suzhou 215031, China.
X Q LiDepartment of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
J F ZhouTianjin Kingmed Diagnostics Laboratory Co.Ltd, Tianjin 300392, China.
Q JiangPeking University People's Hospital, Peking University Institute of Hematology, Beijing 100044, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Fusion Proteins, bcr-ablLeukemia, Myelogenous, Chronic, BCR-ABL PositivePolymerase Chain ReactionHumansRNA, MessengerFusion Proteins, bcr-ablRNA, MessengerBCR::ABL1(IS)Conversion factorDigital PCRInter-laboratory comparisonLeukemia, myeloid, chronic

Identifiers

PMID42706170
PMCPMC13575512

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.